Kyle Matthew Kampman

Top grants by award amount

Kyle Matthew Kampman's NIH grant portfolio, ranked by award amount.

• 5UH3DA049694-03UH3

  Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?

  University of Pennsylvania
  $2.7M

  award amount
• 4UF1MH121944-02UF1

  The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions

  University of Pennsylvania
  $2.1M

  award amount
• 1R61DA061206-01R61

  Psilocybin: Capturing brain mechanisms of motivation and neurocognition in individuals with opioid use disorder

  University of Pennsylvania
  $495K

  award amount
• 5UG1DA050209-05UG1

  A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders

  University of Pennsylvania
  $494K

  award amount
• 5R34DA057507-02R34

  Rapid outpatient low-dose initiation of buprenorphine for individuals with OUD using fentanyl

  University of Pennsylvania
  $227.3K

  award amount
• 4U01DK123813-02U01

  UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis

  University of Pennsylvania
  $1

  award amount

Affiliation

Institutions that have administered grants for Kyle Matthew Kampman.

Affiliated with University of Pennsylvania (PA).

Career milestones

Key NIH funding milestones over time.

1. 2024
   First NIH Award
   University of Pennsylvania
2. 2024
   $500K Cumulative Funding
3. 2024
   $1M Cumulative Funding
4. 2024
   $2M Cumulative Funding
5. 2024
   $5M Cumulative Funding
6. 2024
   Entered Top 50% Nationally
   Ranked #829
7. 2024
   Entered Top 25% Nationally
   Ranked #829
8. 2024
   Entered Top 10% Nationally
   Ranked #829
9. 2024
   Entered Top 5% Nationally
   Ranked #829

Related investigators

Other NIH-funded PIs frequently associated with Kyle Matthew Kampman.